Clinical Trial Update: Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic [NA]

View source ↗

Summary

A clinical trial evaluating the metabolic effects of polylactose as a novel prebiotic in pediatric obesity (adolescents and children) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Polylactose (polylactose)

Snippet

Sponsor: University of Minnesota | Conditions: Obesity, Adolescent, Obesity, Childhood | NA | Status: WITHDRAWN